JOHANNESBURG â€” The South African Health Products Regulatory Authority (SAHPRA)  has authorised the commercial use of the Johnson & Johnson COVID-19 vaccine. SAHPRA registered the vaccine with conditions on Wednesday. The single-dose jab is currently being administered to healthcare workers as part of the country's phase 1 vaccination rollout. More than 263,000 health workers have been inoculated since the Sisonke vaccination study was launched on 17 February. The vaccine has a 57% efficacy in preventing moderate to severe forms of the disease. Addressing the nation earlier this week, President Cyril Ramaphosa said 11 million doses of the Johnson & Johnson vaccine had been secured for the country with about 20 million more planned. Download the Eyewitness News app to your iOS  or Android  device.